Manufacturer record
Kaizen Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Kaizen Pharmaceuticals (Himachal Pradesh) was declared Not of Standard Quality in December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: KPT24K08 A, Panik-D Tablets (Pantoprazole Sodium &Domperidone Tablets) (exp Jan 2026). State Lab Karnataka (state lab) found it not of standard quality: test for Disintegration. Listed in the December 2024 alert.
Records by type
1 record linked to Kaizen Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Panik-D Tablets (Pantoprazole Sodium &Domperidone Tablets) | Batch KPT24K08 AMfg Feb 2024 · Exp Jan 2026 | test for DisintegrationDisintegration | State Lab KarnatakaState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.